IFN-λ3 and CCL17 as predictors of disease progression in patients with mild to moderate COVID-19: A cohort study in a real-world setting

Coronavirus disease 2019 (COVID-19) has overwhelmed hospitals worldwide. In Japan, serum interferon lambda 3 (IFN-λ3) and C–C motif ligand (CCL) 17 levels have been used as predictive markers for disease progression to severe COVID-19. However, the relationship between these predictive markers and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekimoto, Yasuhito, Sekiya, Mitsuaki, Nojiri, Shuko, Hayakawa, Eri, Masui, Yoshihiro, Tajima, Manabu, Nishino, Koichi, Nishizaki, Yuji, Takahashi, Kazuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Respiratory Society. Published by Elsevier B.V. 2023
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834168/
https://www.ncbi.nlm.nih.gov/pubmed/36682084
http://dx.doi.org/10.1016/j.resinv.2022.12.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834168/
https://www.ncbi.nlm.nih.gov/pubmed/36682084
http://dx.doi.org/10.1016/j.resinv.2022.12.006

Ejemplares similares